Legal-context guides
Plain-language guides distinguish Colorado’s changing natural medicine rules from the separate legal status of ibogaine. They are designed to help readers identify the policy question before treating it as a treatment question.
Colorado context
Information, not treatment
Independent resource
Services
Guides, comparisons, and research summaries for Boulder-area residents, families, and professionals who need clear context on ibogaine, Colorado policy, and health uncertainty.
Start with the legal overview
A practical boundary
Clarity before conclusions.
Still Threshold 45 is an independent information resource, not a clinic or referral service. Our work separates what Colorado policy says from what people may assume it says, especially where decriminalization, regulated natural medicine services, and federal drug law do not align.
The broader Boulder ibogaine context is a useful starting point for understanding why a local question can require more than one answer. Ibogaine itself is listed as a Schedule I controlled substance under the DEA’s federal drug scheduling framework, a fact that shapes the limits of any Colorado-specific discussion.
Information services
A steadier way to sort the question.
Decision frameworks
Comparison tools help readers organize questions about law, research access, safety screening, and claims. They do not recommend providers or promise that a particular path is appropriate for any individual.
Research summaries
Research summaries place early findings beside their limits, including why clinical evidence should not be confused with authorization or broad availability. For background on the compound, the ibogaine overview can help orient readers before they examine the underlying studies.
Glossary and FAQ context
Definitions and frequently asked questions clarify terms that are often used loosely: decriminalization, regulated access, clinical trial, Schedule I status, and medical advice. The resource’s purpose and approach explain why careful wording matters when policy and health claims overlap.
Evidence in context
Research is not a shortcut around risk.
Information about ibogaine can move quickly from a study, a personal account, or a policy headline to a conclusion that is not supported by the source. Our summaries keep those categories distinct and identify where uncertainty remains.
The U.S. Food and Drug Administration explains that a clinical investigation is conducted under a study protocol and regulatory oversight; that is different from general availability of a drug or treatment.
For readers assessing research pathways, the FDA’s overview of clinical trials and what patients need to know provides a useful baseline for the role of study participation and informed review.
Guided next step
Use information to ask better questions.
For a broader view of how people describe ibogaine pathways and safety considerations, safe ibogaine therapy information may offer additional context. It does not replace legal advice, medical advice, emergency care, or individualized assessment.
When questions involve health, medication, mental health history, or immediate safety, seek qualified professional help. Still Threshold 45 does not provide medical or legal advice.